Skip to content

Next Generation Pharmaceutical Treatments

Somaí is focused on producing Next Generation pharmaceutical grade cannabis-based treatments of superior quality

By spearheading scientific innovation SOMAÍ is actively working to create a novel product range with increased bioavailability, fast absorption and improved flavinoids to meet market demand, particularly in areas of unmet medical need.

With the widest range of API manufacturing capability in the European pharmaceutical cannabis industry and a superior pharmaceutical EU-GMP manufacturing facility in Portugal, SOMAÍ’s proprietary formulations provide multiple combinations of cannabinoid concentrations which can be delivered by soft gel capsules, sublingual strips, oromucosal spray, transdermal patches and other innovative delivery methods.

For more information contact us at: